Study to Evaluate the Role of Itopride HCI in Patients With Irritable Bowel Syndrome With Predominant Constipation
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
Patients suffering from Irritable Bowel Syndrome with predominant constipation will be
provided with the study medication. The study medication will be evaluated for its efficacy
in relieving the symptoms